☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended October 31, 2020
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___________ to ___________
|
New York
|
14-1541629
|
|
State or Other Jurisdiction of Incorporation or Organization
|
I.R.S. Employer Identification No.
|
|
2818 N. Sullivan Rd. Ste 30
|
||
Spokane, WA 99216
|
99216
|
|
Address of Principal Executive Offices
|
Zip Code
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $.01 par value per share
|
KSPN
|
NASDAQ Capital Market
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
Non-accelerated filer ☒
|
Smaller reporting company ☒
|
Emerging growth company ☐
|
Form 10-Q
Page No.
|
||
PART I. FINANCIAL INFORMATION
|
||
3
|
||
3
|
||
4
|
||
5
|
||
6
|
||
7
|
||
8
|
||
23 | ||
28 | ||
28 | ||
PART II. OTHER INFORMATION
|
||
28 | ||
29 | ||
29 | ||
29 | ||
29 | ||
29 | ||
29 | ||
31 |
October 31,
2020
|
February 1,
2020
|
November 2,
2019
|
||||||||||
ASSETS
|
Unaudited
|
Unaudited
|
||||||||||
CURRENT ASSETS
|
||||||||||||
Cash and cash equivalents
|
$
|
2,396
|
$
|
2,977
|
$
|
3,073
|
||||||
Restricted cash
|
950
|
950
|
950
|
|||||||||
Accounts receivable
|
2,465
|
4,139
|
2,182
|
|||||||||
Merchandise inventory
|
27,204
|
17,836
|
22,522
|
|||||||||
Prepaid expenses and other current assets
|
836
|
2,974
|
857
|
|||||||||
Assets held for discontinued operations
|
-
|
51,189
|
94,286
|
|||||||||
Total current assets
|
33,851
|
80,065
|
123,870
|
|||||||||
Restricted cash
|
4,082
|
4,925
|
5,139
|
|||||||||
Fixed assets, net
|
2,343
|
2,190
|
2,102
|
|||||||||
Operating lease right-of-use assets
|
2,887
|
3,311
|
3,404
|
|||||||||
Intangible assets, net
|
989
|
1,760
|
2,810
|
|||||||||
Cash Surrender Value
|
3,438
|
3,353
|
3,212
|
|||||||||
Other assets
|
1,787
|
2,202
|
943
|
|||||||||
TOTAL ASSETS
|
$
|
49,377
|
$
|
97,806
|
$
|
141,480
|
||||||
LIABILITIES
|
||||||||||||
CURRENT LIABILITIES
|
||||||||||||
Accounts payable
|
$
|
8,559
|
$
|
14,447
|
$
|
10,169
|
||||||
Short-term borrowings
|
8,483
|
13,149
|
27,771
|
|||||||||
Accrued expenses and other current liabilities
|
4,745
|
3,521
|
1,717
|
|||||||||
Current portion of operating lease liabilities
|
583
|
534
|
523
|
|||||||||
Current portion of PPP loan
|
1,356
|
-
|
-
|
|||||||||
Liabilities held for discontinued operations
|
-
|
39,410
|
54,138
|
|||||||||
Total current liabilities
|
23,726
|
71,061
|
94,318
|
|||||||||
Operating lease liabilities
|
2,412
|
2,204
|
2,952
|
|||||||||
PPP loan
|
662
|
-
|
-
|
|||||||||
Long-term debt
|
4,581
|
-
|
-
|
|||||||||
Other long-term liabilities
|
15,857
|
20,026
|
19,335
|
|||||||||
TOTAL LIABILITIES
|
47,238
|
93,291
|
116,605
|
|||||||||
SHAREHOLDERS' EQUITY
|
||||||||||||
Preferred stock ($0.01 par value; 5,000,000 shares authorized; none issued)
|
-
|
-
|
-
|
|||||||||
Common stock ($0.01 par value; 200,000,000 shares authorized; 3,235,576, 3,225,627 and 3,225,627 shares issued, respectively)
|
32
|
32
|
32
|
|||||||||
Additional paid-in capital
|
346,470
|
345,102
|
345,043
|
|||||||||
Treasury stock at cost (1,410,378, 1,409,316 and 1,409,316 shares, respectively)
|
(230,169
|
)
|
(230,169
|
)
|
(230,168
|
)
|
||||||
Accumulated other comprehensive loss
|
(1,470
|
)
|
(1,479
|
)
|
(720
|
)
|
||||||
Accumulated deficit
|
(112,724
|
)
|
(108,971
|
)
|
(89,312
|
)
|
||||||
TOTAL SHAREHOLDERS' EQUITY
|
2,139
|
4,515
|
24,875
|
|||||||||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
|
$
|
49,377
|
$
|
97,806
|
$
|
141,480
|
Thirteen Weeks Ended
|
Thirty-nine Weeks Ended
|
|||||||||||||||
October 31,
2020
|
November 2,
2019
|
October 31,
2020
|
November 2,
2019
|
|||||||||||||
Net revenue
|
$
|
38,913
|
$
|
28,616
|
$
|
112,799
|
$
|
98,008
|
||||||||
Cost of sales
|
35,022
|
25,896
|
101,173
|
89,424
|
||||||||||||
Gross profit
|
3,891
|
2,720
|
11,626
|
8,584
|
||||||||||||
Selling, general and administrative expenses
|
4,503
|
5,604
|
17,909
|
19,248
|
||||||||||||
Loss from continuing operations
|
(612
|
)
|
(2,884
|
)
|
(6,283
|
)
|
(10,664
|
)
|
||||||||
Interest expense
|
381
|
200
|
1,015
|
508
|
||||||||||||
Loss from continuing operations before income tax benefit
|
(993
|
)
|
(3,084
|
)
|
(7,298
|
)
|
(11,172
|
)
|
||||||||
Income tax (benefit) expense
|
(3,545
|
)
|
10
|
(3,545
|
)
|
26
|
||||||||||
Income (loss) from continued operations
|
2,552
|
(3,094
|
)
|
(3,753
|
)
|
(11,198
|
)
|
|||||||||
Loss from fye business, net of tax
|
-
|
(20,061
|
)
|
-
|
(27,887
|
)
|
||||||||||
Net income (loss)
|
$
|
2,552
|
$
|
(23,155
|
)
|
(3,753
|
)
|
(39,085
|
)
|
|||||||
BASIC INCOME (LOSS) PER SHARE:
|
||||||||||||||||
Basic and diluted income (loss) per common share
|
$
|
1.40
|
$
|
(12.73
|
)
|
$
|
(2.06
|
)
|
$
|
(21.51
|
)
|
|||||
Weighted average number of common shares outstanding – basic
|
1,825
|
1,819
|
1,823
|
1,817
|
||||||||||||
DILUTED LOSS PER SHARE:
|
||||||||||||||||
Diluted income (loss) per common share
|
$
|
1.39
|
$
|
(12.73
|
)
|
$
|
(2.06
|
)
|
$
|
(21.51
|
)
|
|||||
Weighted average number of common shares outstanding – diluted
|
1,829
|
1,819
|
1,823
|
1,817
|
Thirteen Weeks Ended
|
Thirty-nine Weeks Ended
|
|||||||||||||||
October 31,
2020
|
November 2,
2019
|
October 31,
2020
|
November 2,
2019
|
|||||||||||||
Net income (loss)
|
$
|
2,552
|
$
|
(23,155
|
)
|
$
|
(3,753
|
)
|
$
|
(39,085
|
)
|
|||||
Amortization of pension gain
|
1
|
5
|
3
|
15
|
||||||||||||
Comprehensive income (loss)
|
$
|
2,553
|
$
|
(23,150
|
)
|
$
|
(3,750
|
)
|
$
|
(39,070
|
)
|
Thirteen Weeks Ended October 31, 2020
|
||||||||||||||||||||||||||||||||
Number of shares outstanding
|
Common
Stock
|
Additional
Paid-in
Capital
|
Treasury
Stock
At Cost
|
Accumulated
Other
Comprehensive
Loss
|
Retained
Earnings
(Accumulated
Deficit)
|
Shareholders’
Equity
|
||||||||||||||||||||||||||
Common
Shares
|
Treasury
Shares
|
|||||||||||||||||||||||||||||||
Balance as of May 2, 2020
|
3,236
|
(1,410
|
)
|
$
|
32
|
$
|
346,457
|
$
|
(230,169
|
)
|
$
|
(1,473
|
)
|
$
|
(115,276
|
)
|
$
|
(430
|
)
|
|||||||||||||
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
2,552
|
2,552
|
||||||||||||||||||||||||
Other comprehensive income
|
-
|
-
|
-
|
-
|
-
|
3
|
-
|
3
|
||||||||||||||||||||||||
Amortization of unearned compensation/restricted stock amortization
|
-
|
-
|
-
|
13
|
-
|
-
|
-
|
13
|
||||||||||||||||||||||||
Balance as of October 31, 2020
|
3,236
|
$
|
(1,410
|
)
|
$
|
32
|
$
|
346,470
|
$
|
(230,169
|
)
|
$
|
(1,470
|
)
|
$
|
(112,724
|
)
|
$
|
2,139
|
Thirty-nine Weeks Ended October 31, 2020
|
||||||||||||||||||||||||||||||||
Number of shares outstanding
|
Common
Stock
|
Additional
Paid-in
Capital
|
Treasury
Stock
At Cost
|
Accumulated
Other
Comprehensive
Loss
|
Retained
Earnings
(Accumulated
Deficit)
|
Shareholders’
Equity
|
||||||||||||||||||||||||||
Common
Shares
|
Treasury
Shares
|
|||||||||||||||||||||||||||||||
Balance as of February 1, 2020
|
3,226
|
(1,409
|
)
|
$
|
32
|
$
|
345,102
|
$
|
(230,169
|
)
|
$
|
(1,479
|
)
|
$
|
(108,971
|
)
|
$
|
4,515
|
||||||||||||||
Net Loss
|
-
|
-
|
-
|
-
|
-
|
-
|
(3,753
|
)
|
(3,753
|
)
|
||||||||||||||||||||||
Other comprehensive income
|
-
|
-
|
-
|
-
|
-
|
9
|
-
|
9
|
||||||||||||||||||||||||
Issuance of warrants
|
-
|
-
|
-
|
836
|
-
|
-
|
-
|
836
|
||||||||||||||||||||||||
Vested restricted shares
|
4
|
(1
|
)
|
-
|
(9
|
)
|
-
|
-
|
-
|
(9
|
)
|
|||||||||||||||||||||
Common stock issued- Director grants
|
6
|
-
|
-
|
243
|
-
|
-
|
-
|
243
|
||||||||||||||||||||||||
Amortization of unearned compensation/restricted stock amortization
|
-
|
-
|
-
|
298
|
-
|
-
|
-
|
298
|
||||||||||||||||||||||||
Balance as of October 31, 2020
|
3,236
|
$
|
(1,410
|
)
|
$
|
32
|
$
|
346,470
|
$
|
(230,169
|
)
|
$
|
(1,470
|
)
|
$
|
(112,724
|
)
|
$
|
2,139
|
Thirteen Weeks Ended November 2, 2019
|
||||||||||||||||||||||||||||||||
Number of shares outstanding
|
Common
Stock
|
Additional
Paid-in
Capital
|
Treasury
Stock
At Cost
|
Accumulated
Other
Comprehensive
Loss
|
Accumulated
Deficit
|
Shareholders’
Equity
|
||||||||||||||||||||||||||
Common
Shares
|
Treasury
Shares
|
|||||||||||||||||||||||||||||||
Balance as of August 3, 2019
|
3,224
|
(1,409
|
)
|
$
|
32
|
$
|
344,983
|
$
|
(230,168
|
)
|
$
|
(725
|
)
|
$
|
(66,157
|
)
|
$
|
47,965
|
||||||||||||||
Net Loss
|
-
|
-
|
-
|
-
|
-
|
-
|
(23,155
|
)
|
(23,155
|
)
|
||||||||||||||||||||||
Other comprehensive income
|
-
|
-
|
-
|
-
|
-
|
5
|
-
|
5
|
||||||||||||||||||||||||
Vested restricted shares
|
2
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
Amortization of unearned compensation/restricted stock amortization
|
-
|
-
|
-
|
60
|
-
|
-
|
-
|
60
|
||||||||||||||||||||||||
Balance as of November 2, 2019
|
3,226
|
(1,409
|
)
|
$
|
32
|
$
|
345,043
|
$
|
(230,168
|
)
|
$
|
(720
|
)
|
$
|
(89,312
|
)
|
$
|
24,875
|
Thirty-nine Weeks Ended November 2, 2019
|
||||||||||||||||||||||||||||||||
Number of shares outstanding
|
Common
Stock
|
Additional
Paid-in
Capital
|
Treasury
Stock
At Cost
|
Accumulated
Other
Comprehensive
Loss
|
Accumulated
Deficit
|
Shareholders’
Equity
|
||||||||||||||||||||||||||
Common
Shares
|
Treasury
Shares
|
|||||||||||||||||||||||||||||||
Balance as of February 2, 2019
|
3,222
|
(1,409
|
)
|
$
|
32
|
$
|
344,826
|
$
|
(230,166
|
)
|
$
|
(735
|
)
|
$
|
(50,227
|
)
|
$
|
63,730
|
||||||||||||||
Net Loss
|
-
|
-
|
-
|
-
|
-
|
-
|
(39,085
|
)
|
(39,085
|
)
|
||||||||||||||||||||||
Other comprehensive income
|
-
|
-
|
-
|
-
|
-
|
15
|
-
|
15
|
||||||||||||||||||||||||
Vested restricted shares
|
4
|
-
|
-
|
3
|
(2
|
)
|
-
|
-
|
1
|
|||||||||||||||||||||||
Amortization of unearned compensation/restricted stock amortization
|
-
|
-
|
-
|
214
|
-
|
-
|
-
|
214
|
||||||||||||||||||||||||
Balance as of November 2, 2019
|
3,226
|
(1,409
|
)
|
$
|
32
|
$
|
345,043
|
$
|
(230,168
|
)
|
$
|
(720
|
)
|
$
|
(89,312
|
)
|
$
|
24,875
|
Thirty-nine Weeks Ended
|
||||||||
October 31,
2020
|
November 2,
2019 (1)
|
|||||||
OPERATING ACTIVITIES:
|
||||||||
Net income loss
|
$
|
(3,753
|
)
|
$
|
(39,085
|
)
|
||
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||
Depreciation of fixed assets
|
783
|
2,272
|
||||||
Amortization of intangible assets
|
771
|
858
|
||||||
Stock-based compensation
|
296
|
214
|
||||||
Loss on disposal of fixed assets
|
-
|
27
|
||||||
Write down investment
|
-
|
500
|
||||||
Loss on impairment of long-lived assets
|
-
|
16,035
|
||||||
Amortization of ROU asset
|
424
|
-
|
||||||
Change in cash surrender value
|
(84
|
)
|
(189
|
)
|
||||
Reversal of ASC 740 liability
|
(3,545
|
)
|
||||||
Changes in operating assets and liabilities that provide (use) cash:
|
||||||||
Accounts receivable
|
1,695
|
1,099
|
||||||
Merchandise inventory
|
(9,367
|
)
|
(6,288
|
)
|
||||
Prepaid expenses and other current assets
|
2,531
|
1,190
|
||||||
Other long-term assets
|
-
|
5,274
|
||||||
Accounts payable
|
679
|
(4,335
|
)
|
|||||
Accrued expenses and other current liabilities
|
(5,295
|
)
|
(852
|
)
|
||||
Deferred revenue
|
-
|
(966
|
)
|
|||||
Other long-term liabilities
|
(407
|
)
|
(6,576
|
)
|
||||
Net cash used in operating activities
|
(15,272
|
)
|
(30,822
|
)
|
||||
INVESTING ACTIVITIES:
|
||||||||
Purchases of fixed assets
|
(935
|
)
|
(2,128
|
)
|
||||
Proceeds from sale of fye business
|
11,779
|
-
|
||||||
Capital distribution from joint venture
|
-
|
115
|
||||||
Net cash provided by (used in) investing activities
|
10,844
|
(2,013
|
)
|
|||||
FINANCING ACTIVITIES:
|
||||||||
Proceeds from short term borrowings
|
8,483
|
27,771
|
||||||
Proceeds from long term borrowings
|
4,581
|
-
|
||||||
Proceeds from issuance of warrants
|
836
|
-
|
||||||
Proceeds from PPP loan
|
2,018
|
-
|
||||||
Issuance of director deferred shares and RSUs
|
235
|
-
|
||||||
Payment of short-term borrowings
|
(13,149
|
)
|
-
|
|||||
Net cash provided by (used in) financing activities
|
3,004
|
27,771
|
||||||
Net increase (decrease) in cash, cash equivalents, and restricted cash
|
(1,424
|
)
|
(5,064
|
)
|
||||
Cash, cash equivalents, and restricted cash, beginning of period
|
8,852
|
14,226
|
||||||
Cash, cash equivalents, and restricted cash, end of period
|
$
|
7,428
|
$
|
9,162
|
(1) |
The cash flows related to discontinued operations have not been segregated and are included in the Consolidated Statements of Cash Flows. See footnote 3.
|
•
|
Partner Obsession
|
•
|
Results
|
•
|
Insights Driven
|
•
|
Ownership
|
•
|
Simplicity
|
•
|
Diversity and Teamwork
|
•
|
Innovation
|
Thirteen Weeks Ended
|
Thirty-nine Weeks Ended
|
|||||||||||||||
(In thousands)
|
October 31,
2020
|
November 2,
2019
|
October 31,
2020
|
November 2,
2019
|
||||||||||||
Net revenue
|
$
|
—
|
$
|
40,840
|
$
|
—
|
$
|
127,602
|
||||||||
Cost of goods sold
|
—
|
24,685
|
—
|
76,932
|
||||||||||||
Selling, general and administrative expenses
|
—
|
20,114
|
—
|
61,891
|
||||||||||||
Impairment of long-lived assets
|
—
|
16,035
|
—
|
16,035
|
||||||||||||
Interest expense
|
—
|
28
|
—
|
46
|
||||||||||||
Other expense (income)
|
—
|
(31
|
)
|
—
|
388
|
|||||||||||
Loss from discontinued operations before income taxes
|
—
|
(19,991
|
)
|
—
|
(27,690
|
)
|
||||||||||
Income tax expense
|
—
|
70
|
—
|
197
|
||||||||||||
Loss from discontinued operations, net of tax
|
$
|
—
|
$
|
(20,061
|
)
|
$
|
—
|
$
|
(27,887
|
)
|
(In thousands)
|
October 31,
2020
|
February 1,
2020
|
November 2,
2019
|
|||||||||
Cash
|
$
|
—
|
$
|
—
|
$
|
—
|
||||||
Accounts receivable, net
|
—
|
62
|
2,102
|
|||||||||
Inventories
|
—
|
50,122
|
78,608
|
|||||||||
Other current assets
|
—
|
1,005
|
3,862
|
|||||||||
Property, plant and equipment, net
|
—
|
—
|
2,885
|
|||||||||
Operating lease right-to-use asset
|
—
|
—
|
5,574
|
|||||||||
Other assets
|
—
|
—
|
1,255
|
|||||||||
Total assets of discontinued operations
|
$
|
—
|
$
|
51,189
|
$
|
94,286
|
||||||
Accounts payable
|
$
|
—
|
$
|
9,769
|
$
|
19,825
|
||||||
Accrued liabilities
|
—
|
779
|
3,867
|
|||||||||
Deferred revenue
|
—
|
6,764
|
5,989
|
|||||||||
Current portion of lease liabilities
|
—
|
8,976
|
8,917
|
|||||||||
Operating lease liabilities
|
—
|
11,059
|
13,275
|
|||||||||
Other liabilities
|
—
|
2,063
|
2,265
|
|||||||||
Total liabilities of discontinued operations
|
$
|
—
|
$
|
39,410
|
$
|
54,138
|
Thirty-nine Weeks Ended
|
||||||||
(In thousands)
|
October 31,
2020
|
November 2,
2019
|
||||||
Net cash used in operating activities
|
$
|
—
|
$
|
(26,022
|
)
|
|||
Net cash used in investing activities
|
—
|
(883
|
)
|
|||||
Depreciation and amortization
|
—
|
1,822
|
||||||
Purchases of fixed assets
|
—
|
883
|
Assets sold
|
||||
Inventory
|
$
|
50,122
|
||
Accounts receivable
|
62
|
|||
Prepaid expenses and other current assets
|
654
|
|||
Other assets
|
351
|
|||
fye business assets sold
|
$
|
51,189
|
||
Less liabilities assumed:
|
||||
Accounts payable
|
(9,769
|
)
|
||
Deferred revenue
|
(6,764
|
)
|
||
Accrued expenses and other current liabilities
|
(779
|
)
|
||
Other long-term liabilities
|
(2,063
|
)
|
||
Operating lease liabilities
|
(20,035
|
)
|
||
fye business liabilities assumed
|
$
|
39,410
|
||
Net proceeds
|
$
|
11,779
|
October 31, 2020
|
||||||||||||||||||||
Weighted
Average
Amortization
Period
(in months)
|
Original
Gross
Carrying
Amount
|
Accumulated
Impairment
|
Accumulated
Amortization
|
Net Carrying
Amount
|
||||||||||||||||
Vendor relationships
|
120
|
$
|
19,100
|
$
|
14,587
|
$
|
4,513
|
$
|
-
|
|||||||||||
Technology
|
60
|
6,700
|
2,587
|
3,757
|
356
|
|||||||||||||||
Trade names and trademarks
|
60
|
3,200
|
-
|
2,567
|
633
|
|||||||||||||||
$
|
29,000
|
$
|
17,174
|
$
|
10,837
|
$
|
989
|
(amounts in thousands)
|
February 1,
2020
|
Impairment
Expense
|
Amortization
Expense
|
October 31,
2020
|
||||||||||||
Amortized intangible assets:
|
||||||||||||||||
Technology
|
$
|
647
|
$
|
-
|
$
|
291
|
$
|
356
|
||||||||
Trade names and trademarks
|
1,113
|
-
|
480
|
633
|
||||||||||||
Net amortized intangible assets
|
$
|
1,760
|
$
|
-
|
$
|
771
|
$
|
989
|
Thirteen Weeks Ended
|
Thirty-nine Weeks Ended
|
|||||||||||||||
(amounts in thousands)
|
October 31,
2020
|
November 2,
2019
|
October 31,
2020
|
November 2,
2019
|
||||||||||||
Amortized intangible assets:
|
||||||||||||||||
Vendor relationships
|
$
|
-
|
$
|
29
|
$
|
-
|
$
|
87
|
||||||||
Technology
|
97
|
97
|
291
|
291
|
||||||||||||
Trade names and trademarks
|
160
|
160
|
480
|
480
|
||||||||||||
Total amortization expense
|
$
|
257
|
$
|
286
|
$
|
771
|
$
|
858
|
Fiscal Year
|
Amortization
|
|||
2020
|
$
|
257
|
||
2021
|
732
|
|||
2022
|
-
|
|||
2023
|
-
|
|||
2024
|
-
|
|||
Thereafter
|
-
|
October 31,
2020
|
February 1,
2020
|
November 2,
2019
|
||||||||||
Cash and cash equivalents
|
$
|
2,396
|
$
|
2,977
|
$
|
3,073
|
||||||
Restricted cash
|
5,032
|
5,875
|
6,089
|
|||||||||
Total cash, cash equivalents and restricted cash
|
$
|
7,428
|
$
|
8,852
|
$
|
9,162
|
Employee and Director Stock Award Plans
|
||||||||||||||||||||
Number
of Shares
Subject To
Option
|
Weighted
Average
Exercise
Price
|
Weighted
Average
Remaining
Contractual
Term
|
Other
Share
Awards
(1)
|
Weighted
Average
Grant Fair
Value
|
||||||||||||||||
Balance February 1, 2020
|
129,196
|
$
|
52.11
|
5.8
|
9,945
|
$
|
36.75
|
|||||||||||||
Granted
|
90,402
|
7.04
|
9.9
|
-
|
-
|
|||||||||||||||
Canceled
|
(89,024
|
)
|
51.31
|
-
|
-
|
-
|
||||||||||||||
Exercised
|
-
|
-
|
-
|
(9,945
|
)
|
36.75
|
||||||||||||||
Balance October 31, 2020
|
130,574
|
$
|
21.46
|
7.0
|
-
|
$
|
-
|
|||||||||||||
Exercisable October 31, 2020
|
46,900
|
$
|
47.18
|
3.0
|
-
|
$
|
-
|
(1) |
Other Share Awards include deferred shares granted to Directors and restricted share units granted to executive officers.
|
Thirteen Weeks Ended
|
Thirty-nine Weeks Ended
|
|||||||||||||||
(amounts in thousands)
|
October 31,
2020
|
November 2,
2019
|
October 31,
2020
|
November 2,
2019
|
||||||||||||
Service cost
|
$
|
-
|
$
|
14
|
$
|
-
|
$
|
42
|
||||||||
Interest cost
|
89
|
142
|
267
|
426
|
||||||||||||
Amortization of net gain(1)
|
(3
|
)
|
(5
|
)
|
(9
|
)
|
(30
|
)
|
||||||||
Net periodic pension cost
|
$
|
86
|
$
|
151
|
$
|
258
|
$
|
438
|
(1) |
The amortization of net gain is related to a director retirement plan previously provided by the Company.
|
Thirteen Weeks Ended
|
Thirty-nine Weeks Ended
|
|||||||||||||||
(in thousands, except per share amounts)
|
October 31,
2020
|
November 2,
2019
|
October 31,
2020
|
November 2,
2019
|
||||||||||||
Income (loss) from continuing operations
|
$
|
2,552
|
$
|
(3,094
|
)
|
$
|
(3,753
|
)
|
$
|
(11,198
|
)
|
|||||
Basic income (loss) per common share from continuing operations
|
$
|
1.40
|
$
|
(1.70
|
)
|
$
|
(2.06
|
)
|
$
|
(6.16
|
)
|
|||||
Diluted income (loss) per common share from continuing operations
|
$
|
1.39
|
$
|
(1.70
|
)
|
$
|
(2.06
|
)
|
$
|
(6.16
|
)
|
|||||
Loss from discontinued operations
|
$
|
-
|
$
|
(20,061
|
)
|
$
|
-
|
$
|
(27,887
|
)
|
||||||
Basic and diluted loss per common share from discontinued operations
|
$
|
-
|
$
|
(11.03
|
)
|
$
|
-
|
$
|
(15.35
|
)
|
||||||
Net income (loss)
|
$
|
2,552
|
$
|
(23,155
|
)
|
$
|
(3,753
|
)
|
$
|
(39,085
|
)
|
|||||
Basic income (loss) per common share
|
$
|
1.40
|
$
|
(12.73
|
)
|
$
|
(2.06
|
)
|
$
|
(21.51
|
)
|
|||||
Weighted average number of common shares outstanding – basic
|
1,825
|
1,819
|
1,823
|
1,817
|
||||||||||||
Diluted income (loss) per common share
|
$
|
1.39
|
$
|
(12.73
|
)
|
$
|
(2.06
|
)
|
$
|
(21.51
|
)
|
|||||
Weighted average number of common shares outstanding – diluted
|
1,829
|
1,819
|
1,823
|
1,817
|
•
|
Partner Obsession
|
•
|
Results
|
•
|
Insights Driven
|
•
|
Ownership
|
•
|
Simplicity
|
•
|
Diversity and Teamwork
|
•
|
Innovation
|
Thirteen Weeks Ended
|
Change
|
Thirty-nine Weeks Ended
|
Change
|
|||||||||||||||||||||||||||||
(amounts in thousands)
|
October 31,
2020
|
November 2,
2019
|
$ |
|
%
|
October 31,
2020
|
November 2,
2019
|
$ |
|
%
|
||||||||||||||||||||||
Net Revenue
|
$
|
38,913
|
$
|
28,616
|
$
|
10,297
|
36.0
|
%
|
$
|
112,799
|
$
|
98,008
|
$
|
14,791
|
15.1
|
%
|
||||||||||||||||
Gross profit
|
3,891
|
2,720
|
1,171
|
43.1
|
%
|
11,626
|
8,584
|
3,042
|
35.4
|
%
|
||||||||||||||||||||||
% to sales
|
10.0
|
%
|
9.5
|
%
|
10.3
|
%
|
8.8
|
%
|
Thirteen Weeks Ended
|
Thirty-Nine Weeks Ended
|
|||||||||||||||||||||||
October 31, 2020
|
November 2, 2019
|
Change
|
October 31, 2020
|
November 2, 2019
|
Change
|
|||||||||||||||||||
Amazon US
|
93.2
|
%
|
96.1
|
%
|
-2.9
|
%
|
94.3
|
%
|
96.0
|
%
|
-1.7
|
%
|
||||||||||||
Amazon International
|
5.3
|
%
|
3.3
|
%
|
2.0
|
%
|
4.5
|
%
|
3.3
|
%
|
1.2
|
%
|
||||||||||||
Walmart & Other Marketplaces
|
0.5
|
%
|
0.2
|
%
|
0.3
|
%
|
0.5
|
%
|
0.3
|
%
|
0.2
|
%
|
||||||||||||
Subtotal Retail
|
99.0
|
%
|
99.6
|
%
|
-0.6
|
%
|
99.3
|
%
|
99.6
|
%
|
-0.4
|
%
|
||||||||||||
Subscriptions & Other
|
1.0
|
%
|
0.4
|
%
|
0.6
|
%
|
0.7
|
%
|
0.4
|
%
|
0.4
|
%
|
||||||||||||
Total
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
Thirteen Weeks Ended
|
Change
|
Thirty-nine Weeks Ended
|
Change
|
|||||||||||||||||||||||||||||
(amounts in thousands)
|
October 31,
2020
|
November 2,
2019
|
$ |
|
%
|
October 31,
2020
|
November 2,
2019
|
$ |
|
%
|
||||||||||||||||||||||
Kaspien SG&A
|
$
|
4,123
|
$
|
4,139
|
$
|
(16
|
)
|
(0.4
|
)%
|
$
|
12,320
|
$
|
12,223
|
$
|
97
|
0.1
|
%
|
|||||||||||||||
Corporate SG&A expenses
|
380
|
1,465
|
(1,085
|
)
|
(74.1
|
)%
|
5,589
|
7,025
|
(1,436
|
)
|
(20.4
|
)%
|
||||||||||||||||||||
Total SG&A expenses
|
$
|
4,503
|
$
|
5,604
|
$
|
(1,101
|
)
|
(19.6
|
)%
|
$
|
17,909
|
$
|
19,248
|
$
|
(1,339
|
)
|
(7.0
|
)%
|
||||||||||||||
As a % of total revenue
|
11.6
|
%
|
19.6
|
%
|
15.9
|
%
|
19.6
|
%
|
As of or for the
Thirty-nine Weeks Ended
|
Change
|
|||||||||||||
(amounts in thousands)
|
October 31,
2020
|
November 2,
2019
|
|
$ | ||||||||||
Operating Cash Flows
|
$
|
(15,272
|
)
|
$
|
(39,085
|
)
|
$
|
23,813
|
||||||
Investing Cash Flows
|
10,884
|
(2,013
|
)
|
12,897
|
||||||||||
Financing Cash Flows
|
3,004
|
27,771
|
(24,767
|
)
|
||||||||||
Capital Expenditures
|
(1)
|
(935
|
)
|
(2,128
|
)
|
1,193
|
||||||||
Cash, Cash Equivalents, and Restricted Cash
|
(2)
|
7,428
|
9,162
|
(1,734
|
)
|
|||||||||
Merchandise Inventory
|
27,204
|
22,522
|
4,682
|
|||||||||||
(1)
|
Included in Investing Cash Flows
|
|||||||||||||
(2)
|
Cash and cash equivalents per condensed consolidated balance sheets
|
$
|
2,396
|
$
|
3,073
|
(677
|
)
|
|||||||
Add: restricted cash
|
5,032
|
6,089
|
(1,057
|
)
|
||||||||||
Cash, cash equivalents, and restricted cash
|
$
|
7,428
|
$
|
9,162
|
$
|
(1,734
|
)
|
(A) Exhibits -
|
|
Exhibit No.
|
Description
|
Certificate of Amendment of Certificate of Incorporation of Trans World Entertainment Corporation, dated September 3, 2020 – incorporated herein by reference to Exhibit 3.1 to
the Company’s Form 8-K filed on September 3, 2020. Commission File No. 0-14818.
|
|
|
|
Amendment No. 2 to Bylaws of Kaspien Holdings Inc., dated September 3, 2020 – incorporated herein by reference to Exhibit 3.2 to the Company’s Form 8-K filed on September 3,
2020. Commission File No. 0-14818.
|
|
|
|
Chief Executive Officer certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
Chief Financial Officer certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
Certification pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
101.INS
|
XBRL Instance Document (furnished herewith)
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema (furnished herewith)
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase (furnished herewith)
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase (furnished herewith)
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase (furnished herewith)
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase (furnished herewith)
|
December 15, 2020
|
By: /s/ Kunal Chopra
|
||
Kunal Chopra
|
|||
Principal Executive Officer
|
|||
(Principal Executive Officer)
|
December 15, 2020
|
By: /s/ Edwin Sapienza
|
||
Edwin Sapienza
|
|||
Chief Financial Officer
|
|||
(Principal and Chief Accounting Officer)
|